Autologous haematopoietic stem cell transplantation (AHSCT) is a multistep procedure that
enables destruction of the immune system and its reconstitution from haematopoietic stem …

Introduction In 1995, the use of autologous hematopoietic stem-cell transplantation
(AHSCT), which was previously used to treat hematological tumors, was introduced for …

These updated EBMT guidelines review the clinical evidence, registry activity and
mechanisms of action of haematopoietic stem cell transplantation (HSCT) in multiple …

Objective: To summarize the evidence on immunoablative therapy followed by autologous
hematopoietic stem cell transplantation (aHSCT) to manage severe and treatment-refractory …

In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune
diseases (ADs) were published, while an international coordinated clinical programme was …

Autologous haematopoietic stem cell transplantation (aHSCT) is gaining traction as a
valuable treatment option for patients affected by severe multiple sclerosis (MS), particularly …

Autologous hematopoietic SCT (AHSCT) has been investigated in the past as a therapeutic
alternative for multiple sclerosis (MS). Despite advances in clinical management, knowledge …

Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune disease of
the central nervous system (CNS). Disease-modifying therapies (DMT) targeting …

High dose immunosuppression followed by autologous hematopoietic stem cell
transplantation (AHSCT) induces prolonged clinical remission in multiple sclerosis (MS) …

High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell
transplantation (AHSCT) is a promising approach to treatment of multiple sclerosis (MS) …